Individualized intensified antiplatelet therapy based on platelet reactivity testing reduces the incidence of cardiovascular events in patients undergoing percutaneous coronary intervention

Spartalis, Michael; Tzatzaki, Eleni; Nikiteas, Nikolaos I.; Spartalis, Eleftherios

doi:10.14744/AnatolJCardiol.2017.8009

Letter to The Editor

Individualized intensified antiplatelet therapy based on platelet reactivity testing reduces the incidence of cardiovascular events in patients undergoing percutaneous coronary intervention

Michael Spartalis ¹ , Eleni Tzatzaki ¹ , Nikolaos I. Nikiteas ² , Eleftherios Spartalis ²

¹Division of Cardiology, Onassis Cardiac Surgery Center, Athens-Greece
²Laboratory of Experimental Surgery and Surgical Research, University of Athens Medical School, Athens-Greece

Anatol J Cardiol 2017; 5(18): 376-377 PubMed ID: 29145223 PMCID: 5731292 DOI: 10.14744/AnatolJCardiol.2017.8009

Full Text PDF